Lexogen

Executive Summary

Lexogen, founded in 2007 and headquartered in Vienna, Austria, is a privately held biotechnology company specializing in next-generation sequencing (NGS) tools and services, with a particular focus on RNA analysis. The company offers proprietary library preparation kits, customizable sequencing services, and bioinformatics solutions, enabling end-to-end workflows for academic, pharmaceutical, and diagnostic researchers. By driving innovations in RNA science, Lexogen empowers precision research and aims to accelerate breakthroughs in genomics and diagnostics. Despite being privately held and lacking public funding details, the company has established a niche in the competitive NGS market through its specialized RNA-focused product portfolio.

Upcoming Catalysts (preview)

• TBDLaunch of Novel RNA Library Preparation Kit70% success
• TBDStrategic Partnership with Major Pharma or Diagnostic Firm50% success
• TBDExpansion into Clinical Diagnostics Market40% success